We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App





Disposable Helmet Retains Cough Droplets and Decreases Risk of COVID-19 Transmission from Patients

By HospiMedica International staff writers
Posted on 14 Jan 2021
A newly-designed open-faced helmet for patient use that is connected to a medical-grade air filtration pump from the top creates a reverse flow of air to prevent cough droplets from exiting the helmet, thus reducing the risk of COVID-19 infection for medical specialists who come in contact with symptomatic or asymptomatic patients.

In a computer simulation using computational fluid dynamics, researchers from Cornell University (Ithaca, NY, USA) who designed the device showed that the helmet design can contain 99.6% of droplets emitted from coughing within 0.1 seconds. More...
Currently available personal protective equipment does not provide open face access while maintaining high effectiveness in containing contaminants. The proposed helmet has a shell that is one millimeter thick and fully encloses the head with access and vacuum ports. A nozzle is attached to the access port to extend the distance droplets must travel against the flow and minimize their chance of escape through the opening, allowing for a smoother flow transition that reduces patient discomfort generated by flow turbulence.

The proposed helmet design could also greatly reduce cost by replacing current practices. For example, building a negative pressure room with air filtration can cost tens of thousands of dollars. The cost of each helmet could be as cheap as couple of dollars if made disposable, said the researchers. Medical-grade HEPA filter negative air machines designed to power the helmets are readily available and cost around USD 1,000.

“To put this into context, if we use the same air pump to create a negative pressure isolation room, it will take about 45 minutes to remove 99.0% of the airborne contaminants from the room,” said study author Mahdi Esmaily.

“Our next step is to refine the helmet design to have higher efficiency and broader application,” added author Dongjie Jia. “After that, we plan to build prototypes of the helmet and perform experiments to verify our simulation predictions.”

Related Links:
Cornell University


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.